on Zomedica Corp. (NASDAQ:ZOM)
Zomedica Expands Equine Distribution Partnership with Grovet in Europe
Zomedica Corp., a veterinary health company, has announced an expansion of its distribution agreement with Grovet in Europe. This move grants Grovet the exclusive distribution rights for Zomedica's PulseVet® and TRUFORMA product platforms across 27 European countries, including major markets like Germany, France, and Spain. In Italy and the UK, these rights are non-exclusive.
This development will allow the introduction of the TRUFORMA equine platform in Europe, complementing the existing PulseVet offerings. The updated agreement also includes potential future products, such as assays for eACTH and Cortisol, beneficial for diagnosing common equine conditions.
Kevin Klass from Zomedica highlighted Grovet's reliability as a partner, while Grovet's Koen Schmitz emphasized the scientific foundation of Zomedica's products. This partnership aims to enhance the company's presence in the European equine healthcare market.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Zomedica Corp. news